Press Release
Bolt Biotherapeutics Announces Issuance of U.S. Patent for the Boltbody™ [...]
Publication
Phase 1/2 study of novel HER2-targeting, TLR7/8 immune-stimulating antibody conjugate [...]
Press Release
Bolt Biotherapeutics Appoints William P. Quinn as Chief Financial Officer
Press Release
Bolt Biotherapeutics Appoints Edith Perez, M.D., as Chief Medical Officer
Past Event
Bolt invited to present: 2020 Jefferies Virtual Healthcare Conference June [...]
Press Release
Bolt Biotherapeutics Appoints Nathan Ihle, Ph.D., as Vice President of [...]
Media Coverage
Bolt Biotherapeutics Initiates Immunotherapy Trial of Lead Drug Candidate in [...]
Press Release
Bolt Biotherapeutics Announces Initiation of BDC-1001 Clinical Trial in Patients [...]
Media Coverage
Bolt Bio Preps Clinical Trials of Immune-Stimulating Cancer Drug in [...]
Past Event
[av_textblock size='' av-medium-font-size='' av-small-font-size='' av-mini-font-size='' font_color='' color='' id='' custom_class='' av_uid='av-ke63jac4' [...]